Dimension Capital’s $800M third fund shows the intersection of science and compute is booming
Dimension Capital has raised an $800 million third fund to invest in startups operating at the intersection of biotechnology and software. The firm has seen rapid growth, backing high-profile AI and drug discovery companies like Chai Discovery and Anthropic.
While many newer VC firms are still struggling to raise fresh capital, Dimension Capital, founded in late 2022, has been raising increasingly larger funds in quick succession. On Tuesday, the New York firm — which invests at the intersection of science and compute — announced an $800 million fund, which is 60% larger than its $500 million second vehicle announced just 18 months ago.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in